- Home
- XNCR vs CLOV Comparison
XNCR vs CLOV Comparison
Compare XNCR & CLOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | XNCR | CLOV |
|---|---|---|
| Founded | 1997 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 881.9M | 1.0B |
| IPO Year | 2013 | 2020 |
Fundamental Metrics
Financial Performance| Metric | XNCR | CLOV |
|---|---|---|
| Price | $13.52 | $2.13 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 10 | 2 |
| Target Price | ★ $22.78 | $3.35 |
| AVG Volume (30 Days) | 429.4K | ★ 5.4M |
| Earning Date | 05-22-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 65.36 | 38.03 |
| EPS | N/A | ★ N/A |
| Revenue | $125,576,000.00 | ★ $1,371,131,000.00 |
| Revenue This Year | $18.68 | $41.68 |
| Revenue Next Year | N/A | $43.92 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 13.65 | N/A |
| 52 Week Low | $6.92 | $1.95 |
| 52 Week High | $18.69 | $4.05 |
Technical Indicators
Market Signals| Indicator | XNCR | CLOV |
|---|---|---|
| Relative Strength Index (RSI) | 60.87 | 45.55 |
| Support Level | $12.57 | $2.12 |
| Resistance Level | $15.59 | $2.78 |
| Average True Range (ATR) | 0.83 | 0.08 |
| MACD | 0.24 | 0.02 |
| Stochastic Oscillator | 70.96 | 72.95 |
Price Performance
Historical ComparisonAbout XNCR Xencor Inc.
Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab, and XmAb657. The group earns its revenue from collaboration agreements, product licensing agreements, and technology licensing agreements.
About CLOV Clover Health Investments Corp.
Clover Health Investments Corp is a healthcare technology company. It focuses on empowering Medicare physicians to proactively manage chronic diseases through its proprietary software platform, Clover Assistant. This cloud-based solution provides personalized insights to physicians, enabling early detection and management of chronic conditions. It operates in one segment: Insurance, through which it offers PPO and HMO plans to Medicare Advantage members in several states.